$AVR

L1 Capital Pty Ltd purchased $6.7M of AVR (indirect holdings)

L1 Capital Pty Ltd purchased 884,809 indirectly-held shares of Anteris Technologies Global Corp. (AVR) at an average of $7.58 ($7.51–$7.78, $6.71M total) across 2 trades over 2026-10-02 to 2026-10-05.

Original reporting
SEC EDGAR · L1 Capital Pty Ltd
Published Oct 6, 2026, 10:18 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 10:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AVR
Bullish
high confidence
Mentioned
$AVR
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVRBullishLow
01

Why it matters

The $6.7M purchase by a 10% owner may be interpreted as a bullish signal, but the amount is modest relative to market cap.

02

Market read

New insider purchase provides fresh data for traders; impact likely limited to short‑term price support.

03

What to watch

Potential hidden risks in AVR's pipeline or market conditions that the insider may be aware of.

Relevance 7/10Novelty 6/10Timing: after-market today

Background

Form 4 filings disclose insider trades and are primary sources for new ownership changes.

Company-level read

Ticker impact

$AVRBullishHigh confidence
Context

SEC Form 4 shows L1 Capital Pty Ltd bought $6.7M of AVR shares, increasing its stake to 12.8M shares.

Expected impact

modest upside as traders price in insider confidence

Evidence & confidence

The purchase is a fresh, material insider transaction (10% owner) disclosed for the first time, indicating strong belief in the company's prospects.

Market effects

Limited; the transaction is company‑specific and does not affect the broader sector.

Minimal; only relevant to investors tracking AVR.

Low; no global macro implications.

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a strong endorsement.

Key entities

  • L1 Capital Pty Ltd

    Purchaser and 10% owner of AVR.

  • Anteris Technologies Global Corp.

    Company whose shares were purchased.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AVRMed

Anteris Advances DurAVR Toward Commercialization; PARADIGM Trial Expands U.S. Recruitment

Anteris Technologies Global Corp. (AVR) reported Q2 2026 results and said it secured U.S. Medicare reimbursement eligibility for PARADIGM Trial procedures. The company began U.S. recruitment, with first patients treated in May 2026, and said the trial is recruiting in the U.S., Denmark and the Netherlands. Net operating cash outflow was $20.8M; R&D expense was $23.4M.

$AVRMed

Anteris Technologies advances PARADIGM Trial in June quarter as US patient recruitment gets underway

Anteris Technologies (ASX:AVR, NASDAQ:AVR) said it advanced its pivotal PARADIGM Trial in the June quarter, enrolling and treating its first US patients after CMS Medicare reimbursement eligibility for qualifying procedures. Recruitment expanded to the US, Denmark and the Netherlands, with Canada and France receiving regulatory clearance. The trial targets about 1,000 patients. Net operating cash outflows were US$20.8m.

$AVRMedAI 8/10

Anteris Technologies Announces Results for the Second Quarter of 2026

Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) reported Q2 2026 results for the quarter ended June 30, 2026. It said CMS granted Medicare reimbursement eligibility for the PARADIGM Trial, U.S. recruitment began with first patients treated in May 2026, and the trial expanded to multiple regions. Net operating cash outflows were $20.8M; R&D expenses were $23.4M.

$AVRLow

Anteris Technologies Announces Results for the Second Quarter of 2026

Anteris Technologies Global Corp. (AVR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Anteris Technologies Announces Results for the Second Quarter of 2026 MINNEAPOLIS, United States and BRISBANE, Australia August 12, 2026 (AEST) Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committe